This brand name is authorized in Australia, Austria, Brazil, Croatia, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Turkey, UK.
The drug CYMEVENE contains one active pharmaceutical ingredient (API):
1
|
UNII
02L083W284 - GANCICLOVIR SODIUM
|
|
Ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl)guanine or DHPG, is a broadspectrum virustatic agent which inhibits the replication of viruses, including viruses of the herpes group, both in vivo and in vitro: herpes simplex types 1 and 2 (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes zoster (HZV). |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| CYMEVENE Powder for concentrate for solution | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J05AB06 | Ganciclovir | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 10328N, 5749N, 6136Y |
| BR | Câmara de Regulação do Mercado de Medicamentos | 529201302152315 |
| EE | Ravimiamet | 1022252, 1085228, 1825275, 1826276 |
| ES | Centro de información online de medicamentos de la AEMPS | 58266 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 169557 |
| GB | Medicines & Healthcare Products Regulatory Agency | 43515 |
| HK | Department of Health Drug Office | 60055 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-230718931 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 3472 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1002130 |
| MT | Medicines Authority | AA565/19902, AA729/00202 |
| NL | Z-Index G-Standaard, PRK | 27065 |
| NZ | Medicines and Medical Devices Safety Authority | 5931 |
| PL | Rejestru Produktów Leczniczych | 100016430, 100257865, 100296256, 100310708, 100347090, 100425736 |
| SG | Health Sciences Authority | 05051P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8680979254059 |
| ZA | Health Products Regulatory Authority | Y/20.2.8/291 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.